Your browser doesn't support javascript.
loading
Atorvastatin Pretreatment Ameliorates Mesenchymal Stem Cell Migration through miR-146a/CXCR4 Signaling.
Li, Na; Guo, Xue-Yuan; Zhou, Jian; Yan, Xian-Liang; Yu, Fang-Fang.
Affiliation
  • Li N; Beijing Key Laboratory of Hypertension, Department of Cardiology, Beijing Chaoyang Hospital, Capital Medical University, Gongti South Road, No. 8, Beijing, 100020, China. niuniulina@163.com.
  • Guo XY; Department of Cardiology, Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Diseases, Capital Medical University, Beijing, 100029, China.
  • Zhou J; Beijing Key Laboratory of Hypertension, Department of Cardiology, Beijing Chaoyang Hospital, Capital Medical University, Gongti South Road, No. 8, Beijing, 100020, China.
  • Yan XL; Department of Cardiology, Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Diseases, Capital Medical University, Beijing, 100029, China.
  • Yu FF; Department of Radiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.
Tissue Eng Regen Med ; 18(5): 863-873, 2021 10.
Article in En | MEDLINE | ID: mdl-34260048
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, CXCR4 / MicroRNAs / Mesenchymal Stem Cells / Atorvastatin Limits: Animals Language: En Journal: Tissue Eng Regen Med Year: 2021 Document type: Article Affiliation country: China Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, CXCR4 / MicroRNAs / Mesenchymal Stem Cells / Atorvastatin Limits: Animals Language: En Journal: Tissue Eng Regen Med Year: 2021 Document type: Article Affiliation country: China Country of publication: